Kyushu Tong Pharmaceutical Group Co., Ltd. started in 1985 at the beginning of reform and opening up. It is a joint-stock enterprise with core businesses of Western medicine, Chinese medicine and medical device wholesale, logistics and distribution, retail chain and e-commerce. In 2009, the company's tax-included sales statistics index was 22 billion yuan. It was the largest private enterprise in Hubei Province. It ranked third among nearly 10,000 pharmaceutical commercial enterprises across the country, and ranked first among China's private pharmaceutical commercial enterprises. Shortlisted for the 'Top 500 Chinese Enterprises'. As of 2009, the company has total assets of more than 7 billion yuan and more than 70 subsidiaries. On November 28, 2008, Kyushu Tong Group Co., Ltd. was officially changed to Kyushu Tong Pharmaceutical Group Co., Ltd. Listed on the Shanghai Stock Exchange on November 2, 2010. (Stock abbreviation: 'Kyushu Pass', stock code: 600998)

In August 2016, Kyushu Pharmaceutical Group ranked 269th among the '2016 Top 500 Chinese Enterprises'. In July 2019, won the National Model Labor Relations Harmonious Enterprise. On August 22, 2019, 2019 China Top 100 Private Enterprises Service Industry was released, and Kyushu Tong Pharmaceutical Group Co., Ltd. ranked 22nd. On September 1, 2019, the list of the top 500 Chinese service industry companies was released in Jinan, and Kyushu Pharmaceutical Group Co., Ltd. ranked 87th.